Evidence map›Paper›PMID 39472782›Full record

ArticleBMC medical imaging2024

Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET/MR in patients with non-small cell lung cancer.

Han Jiang, Ziqiang Li, Nan Meng, Yu Luo, Pengyang Feng, Fangfang Fu, Yang Yang, Jianmin Yuan, Zhe Wang, Meiyun Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Prognostic utility ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Trial
  3. Article
  4. The role ofFrontiers in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Han Jiang *Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Ziqiang Li *Department of Magnetic Resonance, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Nan Meng *Department of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Yu LuoZhengzhou University People's Hospital, Zhengzhou, Henan, China.
Pengyang FengHenan University People's Hospital, Zhengzhou, Henan, China.
Fangfang FuDepartment of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Yang YangBeijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China.
Jianmin YuanCentral Research Institute, United Imaging Healthcare Group, Shanghai, China.
Zhe WangCentral Research Institute, United Imaging Healthcare Group, Shanghai, China.
Meiyun WangDepartment of Medical Imaging, Henan Provincial People's Hospital, Zhengzhou, Henan, China. mywang@zzu.edu.cn.

Funding

Henan Province Medical Science and technology public relations plan joint project LHGJ20210001Henan provincial science and technology research projects 212102310689medical science and technology project of Henan Province SBGJ202101002Zhengzhou Collaborative Innovation Major Project 20XTZX05015
6 · The paper itself

Abstract

backgroundMultiple models intravoxel incoherent motion (IVIM) based

objectiveTo compare the value of METERIAL AND

methodsChest PET and IVIM scans were performed on 61 NSCLC patients using PET/MR. The maximum standard uptake value (SUV

results61 NSCLC patients had an overall median OS of 18 months (14.75, 22.85) and a median PFS of 17 months (12.00, 21.75). Univariate analysis showed that pathological subtype, TNM stage, surgery, SUV

conclusionMTV, D* and ADC are independent predicting factors affecting OS and PFS in NSCLC patients.

Indexed as

Carcinoma, Non-Small-Cell LungFluorodeoxyglucose F18Lung NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsAdultAgedAged, 80 and overDiffusion Magnetic Resonance ImagingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingPredictive Value of TestsFluorodeoxyglucose F18RadiopharmaceuticalsDiffusion parametersMagnetic resonance imagingMetabolic parametersNon-small cell lung cancerPositron emission computed tomography

Identifiers

PMID39472782
PMCPMC11523797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.